Picture of Carna Biosciences logo

4572 — Carna Biosciences News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Table: Garna Biosciences - 6-MTH group results

Aug 7 (Reuters)- 
             Garna Biosciences Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended        Year to   
                  Jun 30, 2020        Jun 30, 2019       Dec 31, 2020  
                     LATEST             YEAR-AGO            LATEST     
                     RESULTS             RESULTS           FORECAST    
  Sales              579 mln              2.46               1.04      
                   (-76.4 pct)        (+516.6 pct)       (-67.7 pct)   
  Operating       loss 375 mln            1.45            loss 1.78    
  Recurring       loss 380 mln            1.45            loss 1.79    
  Net             loss 397 mln            1.20            loss 1.82    
  EPS            loss 32.60 yen        113.86 yen      loss 156.45 yen 
  EPS Diluted                          112.54 yen                      
  Ann Div                                  NIL               NIL       
  -Q2 div              NIL                 NIL                         
  -Q4 div                                  NIL               NIL       
  
  NOTE - Garna Biosciences Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T

Recent news on Carna Biosciences

See all news